Prevalence, Predictors, and Outcomes of Type 2 NSTEMI in Hospitalized Patients With COVID-19.

Sahishnu PatelAlexis VisotckyAdam Devine Vishwajit Kode Srisha Kotlo Michael Aljadah Rodney A Sparapani Jacquelyn Kulinski

Published in: Journal of the American Heart Association (2024)

In hospitalized patients with COVID-19, those with a T2MI compared with those without had higher morbidity and mortality. Outpatient anti-hyperglycemic and anti-coagulation use were the only pre-admission factors associated with reduced odds of T2MI.

Keyphrases

emergency department
risk factors
type diabetes
metabolic syndrome
skeletal muscle
insulin resistance